Literature DB >> 22178256

Deletion of the RMGA and CHD2 genes in a child with epilepsy and mental deficiency.

Leonardo P Capelli1, Ana C V Krepischi, Juliana Gurgel-Giannetti, Mirian Fabiola S Mendes, Tatiane Rodrigues, Monica C Varela, Célia P Koiffmann, Carla Rosenberg.   

Abstract

We describe a novel chromosome microdeletion at 15q26.1 detected by oligo-array-CGH in a 6-year-old girl presenting with global development delay, epilepsy, autistic behavior and facial dysmorphisms. Although these features are often present in Angelman syndrome, no alterations were present in the methylation pattern of the Prader-Willi-Angelman critical region. The deletion encompasses only 2 genes: CHD2, which is part of a gene family already involved in CHARGE syndrome, and RGMA which exerts a negative control on axon growth. Deletion of either or both genes could cause the phenotype of this patient. These results provide a further chromosome region requiring evaluation in patients presenting Angelman features.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178256     DOI: 10.1016/j.ejmg.2011.10.004

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  21 in total

1.  De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.

Authors:  Arvid Suls; Johanna A Jaehn; Angela Kecskés; Yvonne Weber; Sarah Weckhuysen; Dana C Craiu; Aleksandra Siekierska; Tania Djémié; Tatiana Afrikanova; Padhraig Gormley; Sarah von Spiczak; Gerhard Kluger; Catrinel M Iliescu; Tiina Talvik; Inga Talvik; Cihan Meral; Hande S Caglayan; Beatriz G Giraldez; José Serratosa; Johannes R Lemke; Dorota Hoffman-Zacharska; Elzbieta Szczepanik; Nina Barisic; Vladimir Komarek; Helle Hjalgrim; Rikke S Møller; Tarja Linnankivi; Petia Dimova; Pasquale Striano; Federico Zara; Carla Marini; Renzo Guerrini; Christel Depienne; Stéphanie Baulac; Gregor Kuhlenbäumer; Alexander D Crawford; Anna-Elina Lehesjoki; Peter A M de Witte; Aarno Palotie; Holger Lerche; Camila V Esguerra; Peter De Jonghe; Ingo Helbig
Journal:  Am J Hum Genet       Date:  2013-10-24       Impact factor: 11.025

Review 2.  Architects of the genome: CHD dysfunction in cancer, developmental disorders and neurological syndromes.

Authors:  Wangzhi Li; Alea A Mills
Journal:  Epigenomics       Date:  2014       Impact factor: 4.778

3.  Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.

Authors:  Joanna A Korecka; Elizabeth B Moloney; Ruben Eggers; Barbara Hobo; Sanny Scheffer; Nienke Ras-Verloop; R Jeroen Pasterkamp; Dick F Swaab; August B Smit; Ronald E van Kesteren; Koen Bossers; Joost Verhaagen
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

4.  CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures.

Authors:  Rhys H Thomas; Lin Mei Zhang; Gemma L Carvill; John S Archer; Sinéad B Heavin; Simone A Mandelstam; Dana Craiu; Samuel F Berkovic; Deepak S Gill; Heather C Mefford; Ingrid E Scheffer
Journal:  Neurology       Date:  2015-02-11       Impact factor: 9.910

5.  Clinical analysis of CHD2 gene mutations in pediatric patients with epilepsy.

Authors:  Weixing Feng; Fang Fang; Xiaohui Wang; Chunhong Chen; Junlan Lu; Jie Deng
Journal:  Pediatr Investig       Date:  2022-04-26

Review 6.  Nervous system development and disease: A focus on trithorax related proteins and chromatin remodelers.

Authors:  Amanda Moccia; Donna M Martin
Journal:  Mol Cell Neurosci       Date:  2017-11-28       Impact factor: 4.314

7.  Lentiviral Vector-Induced Overexpression of RGMa in the Hippocampus Suppresses Seizures and Mossy Fiber Sprouting.

Authors:  Ling Chen; Baobing Gao; Min Fang; Jie Li; Xiujuan Mi; Xin Xu; Wei Wang; Juan Gu; Bo Tang; Yanke Zhang; Zhihua Wang; Ao Zhan; Guojun Chen; Xuefeng Wang
Journal:  Mol Neurobiol       Date:  2016-02-03       Impact factor: 5.590

8.  CHD2 variants are a risk factor for photosensitivity in epilepsy.

Authors:  Elizabeth C Galizia; Candace T Myers; Costin Leu; Carolien G F de Kovel; Tatiana Afrikanova; Maria Lorena Cordero-Maldonado; Teresa G Martins; Maxime Jacmin; Suzanne Drury; V Krishna Chinthapalli; Hiltrud Muhle; Manuela Pendziwiat; Thomas Sander; Ann-Kathrin Ruppert; Rikke S Møller; Holger Thiele; Roland Krause; Julian Schubert; Anna-Elina Lehesjoki; Peter Nürnberg; Holger Lerche; Aarno Palotie; Antonietta Coppola; Salvatore Striano; Luigi Del Gaudio; Christopher Boustred; Amy L Schneider; Nicholas Lench; Bosanka Jocic-Jakubi; Athanasios Covanis; Giuseppe Capovilla; Pierangelo Veggiotti; Marta Piccioli; Pasquale Parisi; Laura Cantonetti; Lynette G Sadleir; Saul A Mullen; Samuel F Berkovic; Ulrich Stephani; Ingo Helbig; Alexander D Crawford; Camila V Esguerra; Dorothee G A Kasteleijn-Nolst Trenité; Bobby P C Koeleman; Heather C Mefford; Ingrid E Scheffer; Sanjay M Sisodiya
Journal:  Brain       Date:  2015-03-17       Impact factor: 13.501

9.  RGMa regulates cortical interneuron migration and differentiation.

Authors:  Conor O'Leary; Stacey J Cole; Michael Langford; Jayani Hewage; Amanda White; Helen M Cooper
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

10.  Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.

Authors:  Gemma L Carvill; Sinéad B Heavin; Simone C Yendle; Jacinta M McMahon; Brian J O'Roak; Joseph Cook; Adiba Khan; Michael O Dorschner; Molly Weaver; Sophie Calvert; Stephen Malone; Geoffrey Wallace; Thorsten Stanley; Ann M E Bye; Andrew Bleasel; Katherine B Howell; Sara Kivity; Mark T Mackay; Victoria Rodriguez-Casero; Richard Webster; Amos Korczyn; Zaid Afawi; Nathanel Zelnick; Tally Lerman-Sagie; Dorit Lev; Rikke S Møller; Deepak Gill; Danielle M Andrade; Jeremy L Freeman; Lynette G Sadleir; Jay Shendure; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Nat Genet       Date:  2013-05-26       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.